Neuropsychopharmacology
Neuropsychopharmacology is an interdisciplinary field that merges medicine, psychology, and biology to study how pharmacological drugs affect mood and behavior while also examining their impact on brain structures. This field investigates the specific areas of the brain influenced by these drugs, particularly focusing on those designed to treat mental health disorders, including mood disorders, anxiety disorders, and psychotic disorders. A primary goal of neuropsychopharmacology is to develop targeted therapies that are effective with minimal side effects, enhancing the quality of life for individuals dealing with mental illnesses.
Research in neuropsychopharmacology examines various factors that can influence a drug's effect, such as genetic composition and drug interactions. It involves an in-depth study of neurotransmitters, which are vital chemicals in the brain that regulate communication between neurons. Common neurotransmitters of interest include serotonin, dopamine, and GABA, among others. Techniques like functional MRI and PET scans help researchers visualize brain activity, enabling them to identify how specific drugs affect mental states and behaviors. Although psychotropic medications like antidepressants and antipsychotics are widely used, ongoing debates about their efficacy highlight the complexity of mental health treatment. As research advances, neuropsychopharmacology aims to refine therapies that better target the underlying biological mechanisms of mental disorders.
On this Page
Neuropsychopharmacology
Neuropsychopharmacology is an interdisciplinary field of study in medicine, psychology, and biology. It combines the study of the effects of pharmacological drugs on mood and behavior—psychopharmacology—with the study of these same drugs' effects on the physical structures of the brain, which is called neuropharmacology. Together, these two areas of study combine to form neuropsychopharmacology, which aims to determine the specific areas or structures of the brain that are influenced by certain drugs that then alter mood, feelings, or behavior. Although any drug may have the capability to affect the brain, for the purposes of neuropsychopharmacological research, scientists typically study the drugs that are specifically intended to target disorders of the brain and mental illnesses.
Background
Neuropsychopharmacology aims to treat a variety of different mental health conditions, including mood disorders, such as depression or bipolar disorder; sleep disorders; eating disorders, such as anorexia or bulimia; psychotic disorders, such as schizophrenia; and anxiety disorders. The goal is to develop highly targeted, effective therapies with a minimal amount of side effects that will provide lasting relief from the symptoms of the mental illness or disorder, based on the physical structures and chemicals of the brain and the ways in which they respond to treatment with medication.
Currently, a number of different drugs fall into the category of psychopharmacology, including psychotropic drugs like antidepressants or antipsychotics, sedatives, narcotics, and anticonvulsants. These often cause a wide range of side effects, however, which can make the patient less likely to take them as prescribed. Neuropsychopharmacologists study how these types of drugs affect or regulate particular neurons (nerve cells in the brain), receptors, pathways, or other brain structures to alter behavior. The goals of these psychotropic drugs may vary, but often include regulating emotions and mood, enhancing cognitive ability, regulating appetite, and countering the addictive effects of other drugs or the processes that cause craving in the brain.
Overview
There are a number of biological factors that influence the effect a specific drug will have on an individual; this is what psychopharmacology attempts to determine while a drug is undergoing research and testing. These include protein binding, which determines the availability of the medication to the body; half-life, which indicates the amount of time the medication is present in the body; drug interactions, in which one medication can drastically alter the effects of another; and the person's genetic composition, which can also have a significant influence on a drug's effectiveness in the body.
The goal of neuropsychopharmacology, then, is to apply this understanding of a drug's biological effect on the body to the understanding of neuroscience, and to identify the particular areas of the brain, receptors, or neurochemical processes that are responsible for a particular state of mind, behavior, or mental illness. By isolating these neurological influences in this manner, researchers hope to be able to create medications that are highly targeted to the area of the brain or the receptor where they are needed, thereby reducing unpleasant side effects and ensuring that the medication is as effective as possible. An important aspect of this research is the study of neurotransmitters, which are the chemicals that relay information between the brain and body and between neurons in the brain. Many psychotropic drugs are designed to target specific neurotransmitters—to either increase or decrease their availability in the body to induce feelings of calm and positivity. Neuropsychopharmacology hopes not just to isolate the particular neurotransmitter responsible for a mental state but also the neurotransmitter's particular location and pathways in the brain.
Neurotransmitters are typically divided into three categories: amino acids, peptides, and monoamines. Some of the more common neurotransmitters researched in mood and behavior regulation include the amino acids GABA and glutamate, monoamines dopamine and serotonin, and neuropeptides like endorphins and oxytocin. For example, one of the most common types of antidepressants is called a selective serotonin reuptake inhibitor or SSRI. The goal of an SSRI is to increase the amount and availability of the neurotransmitter serotonin in the brain that may have a positive effect on mood. Psychotropic drugs—in particular, antipsychotics and antidepressants—are some of the most widely prescribed drugs in existence today. However, the efficacy of antidepressants is part of an ongoing debate among clinicians and researchers, as some studies have shown that placebos can have equal or greater effectiveness as do commonly prescribed antidepressant medications.
Methods of neuropsychopharmacological research vary. Scientists may use diagnostic imaging tools, such as functional magnetic resonance imaging (MRI), positron emission tomography (PET), or single-photon emission computed tomography (SPECT) scanning, which provide different levels of information about blood flow, activity, and function in the brain. Scientists can then compare the brain scans of individuals suffering from similar mental disorders to identify similarities that can provide information about the areas of the brain that are affected by a particular drug or mental illness. Research is also often conducted through clinical trials with willing patients. The patients participating in the trial are usually unaware whether they are receiving a drug or a placebo, and will report their ongoing mental state and any side effects they experience to the doctor conducting the research. Some psychopharmacological drugs have been developed through clinical trials that were originally intended for a different purpose, but the side effects revealed some benefit to a particular mental health condition (such as a sedating effect for anxiety). It is then the goal of the researchers to determine what neurotransmitter or neuron the drug is targeting and to identify what makes it effective in treating a condition for which it was not originally developed.
Research in the fields of psychopharmacology and neuropsychopharmacology is continuous and evolving as scientists attempt to more fully understand the effects of neurotransmitters and physical brain structures on mental disorders and behavior. The research can also help to determine the possibility of fully isolating the biological or genetic causes of mental illnesses and the therapeutic treatments that are most effective.
Bibliography
Demelash, Sileshi. "The Role of Micronutrient for Depressed Patients." Journal of Neuropsychopharmacology & Mental Health, vol. 2, no. 116, Aug. 2017.
Fields, Deborah. "What Is Neuropsychopharmacology?" News-Medical.net, www.news-medical.net/health/What-is-Neuropsychopharmacology.aspx. Accessed 25 Nov. 2017.
Iversen, Leslie, et al. Introduction to Neuropsychopharmacology. Oxford UP, 2009.
Preston, Kenzie, et al. "Exacerbated Craving in the Presence of Stress and Drug Cues in Drug-Dependent Patients." Neuropsychopharmacology, Nov. 2017.
"Psychopharmacology." Psychology Today, www.psychologytoday.com/basics/psychopharmacology. Accessed 25 Nov. 2017.
Stefanik, Laura, et al. "Brain-Behavior Participant Similarity Networks among Youth and Emerging Adults with Schizophrenia Spectrum, Autism Spectrum, or Bipolar Disorder and Matched Controls." Neuropsychopharmacology, Nov. 2017.
Vignoli, Teo, et al. "Neurobiological Evidence in Alcohol Addiction Can Help Pharmacological Treatment Personalization." Journal of Neuropsychopharmacology & Mental Health, vol. 1, no. e103, Nov. 2015.
"What Is Psychopharmacology." American Society of Clinical Psychopharmacology, www.ascpp.org/resources/information-for-patients/what-is-psychopharmacology/. Accessed 25 Nov. 2017.